Today's Low | Today's High | |
---|---|---|
3,137.25 3,140.25 |
| 3,179.20 3184.30 |
52 Week Low | 52 Week High | |
---|---|---|
1,943.70 (19-Mar-2024) 1,943.20 (19-Mar-2024) |
| 3,653.95 (10-Oct-2024) 3,645.00 (10-Oct-2024) |
Buy Order Quantity | Sell Order Quantity | |
---|---|---|
0 | 5 |
Bid Price | Quantity |
---|---|
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | -- |
Ask Price | Quantity |
---|---|
3,153.45 | 5.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | 5 |
Market Cap: | ₹263.45 Cr |
PE Ratio (TTM): | 60.66 |
PB Ratio: | 12.75 |
Industry P/E: | 65.08 |
Debt to Equity: | - |
ROE: | 21.01 |
EPS (TTM): | 52.16 |
Book Value: | 214.92 |
Face Value: | 10.00 |
Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
---|---|---|---|---|---|
Revenue | 531.70 Cr | 480.10 Cr | 431.00 Cr | 428.40 Cr | 466.90 Cr |
Profit | 113.00 Cr | 93.60 Cr | 71.40 Cr | 62.40 Cr | 78.60 Cr |
Expense | 394.90 Cr | 370.00 Cr | 344.50 Cr | 352.90 Cr | 368.10 Cr |
Comprehensive income | 112.60 Cr | 94.10 Cr | 69.80 Cr | 63.60 Cr | 81.20 Cr |
EPS | 13.57 | 11.25 | 8.58 | 7.50 | 9.44 |
Company name | Listing date | Industry | NSE symbol BSE symbol |
---|---|---|---|
Dr. Lal Path Labs Ltd. | Dec, 2015 Dec, 2015 | Healthcare Service Provider Healthcare Service Provider | LALPATHLAB LALPATHLAB |
Promoters | |
---|---|
54.61% |
Public | |
---|---|
44.98% |
Shares held by Employee Trusts | |
---|---|
0.41% |
Promoters | |
---|---|
55.01% |
Public | |
---|---|
44.55% |
Shares held by Employee Trusts | |
---|---|
0.44% |
Promoters | |
---|---|
55.03% |
Public | |
---|---|
44.45% |
Shares held by Employee Trusts | |
---|---|
0.51% |
Promoters | |
---|---|
55.05% |
Public | |
---|---|
44.39% |
Shares held by Employee Trusts | |
---|---|
0.56% |
Promoters | |
---|---|
55.05% |
Public | |
---|---|
44.38% |
Shares held by Employee Trusts | |
---|---|
0.58% |
Today's stock performance witnessed a fluctuation from a minimum of 3,137.25 on the NSE (National Stock Exchange) to a maximum of 3,179.20. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 3,140.25 to a high of 3,184.30.
The stock's performance over the past 52 weeks reveals a low of 1,943.70 (occurred on 19-Mar-2024) and a high of 3,653.95 (achieved on 10-Oct-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,943.20 (on 19-Mar-2024), and the 52-week high is 3,645.00 (on 10-Oct-2024).
The stock's performance over the past 52 weeks reveals a low of 1,943.70 (occurred on 19-Mar-2024) and a high of 3,653.95 (achieved on 10-Oct-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,943.20 (on 19-Mar-2024), and the 52-week high is 3,645.00 (on 10-Oct-2024).
The total volume is 1, and the total traded value is 34.08 (₹ Lakhs).
The upper circuit limit is 3,482.85, and the lower circuit limit is 2,849.65.
The market cap is ₹263.45 Cr, and the PE ratio (TTM) is 65.08.
The PB ratio is 14.67, industry P/E is 65.08 .
ROE is 21.01, EPS is 52.16, book value is 214.92
In Sep 2023, Revenue is ₹5317000000.00, and Profit is ₹1130000000.00. In Jun 2023, Revenue is ₹4801000000.00, and Profit is ₹936000000.00.
The company, Dr. Lal Path Labs Ltd., was listed in Dec 2015 and belongs to the Healthcare Service Provider industry. Its NSE symbol is LALPATHLAB.
As of latest available update, promoters hold 54.61%, the public holds 44.98%, and Employee Trusts holds 0.41.
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.